Burning Rock Biotech (BNR) Work In Process (2021 - 2023)

Burning Rock Biotech has reported Work In Process over the past 3 years, most recently at $11.3 million for Q4 2023.

  • Quarterly results put Work In Process at $11.3 million for Q4 2023, up 3.89% from a year ago — trailing twelve months through Dec 2023 was $11.3 million (up 3.89% YoY), and the annual figure for FY2023 was $11.5 million, down 0.54%.
  • Work In Process for Q4 2023 was $11.3 million at Burning Rock Biotech, up from $10.9 million in the prior quarter.
  • Over the last five years, Work In Process for BNR hit a ceiling of $11.3 million in Q4 2023 and a floor of $8.9 million in Q4 2021.
  • Median Work In Process over the past 3 years was $10.9 million (2022), compared with a mean of $10.4 million.
  • Biggest five-year swings in Work In Process: grew 22.55% in 2022 and later rose 3.89% in 2023.
  • Burning Rock Biotech's Work In Process stood at $8.9 million in 2021, then rose by 22.55% to $10.9 million in 2022, then increased by 3.89% to $11.3 million in 2023.
  • The last three reported values for Work In Process were $11.3 million (Q4 2023), $10.9 million (Q4 2022), and $8.9 million (Q4 2021) per Business Quant data.